Protein Characterization and Identification Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Product & Services (Consumables, Instruments, Services), By Application (Drug Discovery & Development, Clinical Diagnosis, Others), By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others),
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationProtein Characterization and Identification Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Product & Services (Consumables, Instruments, Services), By Application (Drug Discovery & Development, Clinical Diagnosis, Others), By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others),
Increasing prevalence of chronic diseases
Chronic diseases, such as cancer, diabetes, and cardiovascular diseases, have a significant impact on the growth of the Global Protein Characterization and Identification Market. These diseases are characterized by changes in protein expression, post-translational modifications, and interactions, which can provide valuable information for disease diagnosis, treatment, and drug development. Protein characterization and identification are critical in understanding the molecular mechanisms of chronic diseases, including the identification of disease biomarkers, drug targets, and pathways. The characterization of proteins and their interactions can also provide insights into disease progression and the development of resistance to therapy. The increasing prevalence of chronic diseases is driving the demand for protein characterization and identification.
According to the World Health Organization (WHO), chronic diseases are responsible for 71% of all deaths worldwide, and this number is expected to increase in the coming years. This increasing burden of chronic diseases is driving the need for new and effective therapies, which in turn is driving the demand for protein characterization and identification. Furthermore, the growing demand for personalized medicine is also driving the growth of the global Protein Characterization and Identification market. Personalized medicine aims to provide individualized treatment based on a patient's genetic makeup, lifestyle, and other factors. Protein characterization and identification are critical in the development of personalized medicine, as they enable the identification of disease biomarkers and the development of targeted therapies.
Growing demand for personalized medicine
Personalized medicine is a rapidly growing field that aims to provide individualized treatment based on a patient's genetic makeup, lifestyle, and other factors. The field of personalized medicine is heavily dependent on protein characterization and identification, which is driving the growth of the global Protein Characterization and Identification market. Protein characterization and identification are critical in the development of personalized medicine, as they enable the identification of disease biomarkers and the development of targeted therapies. By characterizing proteins and their interactions, researchers can identify specific proteins that are involved in disease progression and develop targeted therapies that selectively bind to these proteins. Furthermore, the development of new proteomic technologies, such as mass spectrometry and chromatography, is driving the growth of the global Protein Characterization and Identification market. These technologies enable researchers to analyze proteins with greater accuracy and sensitivity, which is critical in the development of personalized medicine. The growing demand for personalized medicine is also driving the growth of the Global Protein Characterization and Identification Market.
Personalized medicine aims to provide individualized treatment based on a patient's genetic makeup, lifestyle, and other factors. Protein characterization and identification are critical in the development of personalized medicine, as they enable the identification of disease biomarkers and the development of targeted therapies. Moreover, the increasing prevalence of chronic diseases is driving the need for new and effective therapies, which in turn is driving the demand for protein characterization and identification. Chronic diseases are characterized by changes in protein expression, post-translational modifications, and interactions, which can provide valuable information for disease diagnosis, treatment, and drug development.
Advancements in proteomic technologies
Advancements in proteomic technologies have had a significant impact on the growth of the global Protein Characterization and Identification market. Proteomic technologies refer to a set of tools and techniques used to study the structure, function, and interactions of proteins in a sample. The development of new proteomic technologies, such as mass spectrometry and chromatography, has enabled researchers to analyze proteins with greater accuracy and sensitivity. These advancements have allowed for the identification and quantification of proteins at much lower concentrations than was previously possible, which has greatly expanded the scope of protein characterization and identification. The high sensitivity and specificity of these technologies are essential for the identification of disease biomarkers and the development of targeted therapies. With the development of proteomic technologies, researchers can identify specific proteins that are involved in disease progression and develop targeted therapies that selectively bind to these proteins. This precision medicine approach has the potential to greatly improve patient outcomes and reduce the risk of side effects associated with traditional treatments.
Furthermore, the use of proteomic technologies in drug development has also driven the growth of the Global Protein Characterization and Identification Market. By analyzing the interactions of proteins with potential drug candidates, researchers can identify compounds with the greatest therapeutic potential and optimize their pharmacological properties. The increasing demand for personalized medicine is also driving the growth of the global Protein Characterization and Identification market. The development of proteomic technologies has enabled the identification of disease biomarkers and the development of targeted therapies, which are critical components of personalized medicine.
Increasing focus on research and development
Research and development (R&D) activities are a key driver of growth in the global Protein Characterization and Identification market. As the demand for protein characterization and identification continues to grow, there is an increasing need for innovative technologies and techniques that can provide faster, more accurate, and more comprehensive analysis of proteins. The investment in R&D activities has led to the development of new tools and techniques for protein characterization and identification, which has expanded the capabilities of the market. For example, the development of new proteomic technologies such as mass spectrometry, protein microarrays, and protein imaging techniques have revolutionized the field of protein analysis, enabling researchers to study proteins in greater detail than ever before. For example, the use of proteomics in drug development is rapidly increasing, with many pharmaceutical companies investing heavily in the development of proteomic-based drug discovery platforms. Additionally, protein characterization and identification are also being used in fields such as agriculture, food science, and environmental science. Academic and research institutions are also investing in R&D activities to further advance the field of protein characterization and identification. This has led to the development of new research tools, technologies, and approaches that have expanded the scope of the market and contributed to its growth.
Availability of government funding
Government funding has a significant impact on the growth of the global Protein Characterization and Identification market. The availability of funding can support research and development activities, promote the adoption of new technologies, and facilitate the commercialization of new products and services. One of the primary ways in which government funding influences the market is through funding for research institutions and universities. Government funding can support academic research, which can lead to the development of new technologies and approaches for protein characterization and identification. This can result in the discovery of new biomarkers and the development of new targeted therapies for a range of diseases, driving the growth of the market. Government funding can support the commercialization of new products and services. This funding can help small and medium-sized enterprises (SMEs) to develop and market their products, which can facilitate the adoption of new technologies and approaches. For example, government funding can support the development of new mass spectrometry or chromatography instruments, which can help to reduce the cost of analysis and increase the accuracy of protein identification. Government funding can support the creation of collaborations and partnerships between academia, industry, and government. These partnerships can help to drive innovation, promote knowledge exchange, and accelerate the development and commercialization of new technologies and approaches.
Download Free Sample Report
Recent Development
- In 2021, Waters Corporation launched the SYNAPT XS MS system, which is a high-performance mass spectrometer designed for protein characterization and identification. The system features advanced data acquisition and processing capabilities, as well as improved sensitivity and resolution.
- In 2020, Thermo Fisher Scientific launched the Orbitrap Exploris 480 mass spectrometer, which is also designed for protein characterization and identification. The system features advanced ion optics and data acquisition capabilities, as well as improved resolution and sensitivity.
- Bio-Rad Laboratories launched the ZE5 Cell Analyzer in 2021. The analyzer is designed for use in protein expression analysis and cell biology research. It features a high-throughput flow cytometer and advanced analysis software for data processing and visualization.
Market Segmentation
Global Protein Characterization and Identification market can be segmented on the basis of product and service, application, end use and by region. Based on the product and service, the market can be segmented into consumables, instruments, and services. Based on application, the market can be segmented into drug discovery & development, clinical diagnosis, and others. Based on end use, the market is further divided into pharmaceuticals & biotechnology companies, academic research institutes, contract research organizations, and others.
Market Players
Agilent Technologies, Analytik Jena, Bio-Rad Laboratories, Bruker Corporation, Cleaver Scientific, Danaher Corporation, Eurofins Scientific, Horiba, Jeol, Merck KGaA, PerkinElmer Inc, Promega Corporation, Qiagen NV are some of the leading players operating in the global Protein Characterization and Identification market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | By Product and Service By Application By End Use By Region |
| Regional scope | North America, Europe, Asia Pacific, South America, Middle East & Africa |
| Country scope | United States, Canada, Mexico, France, Germany, United Kingdom, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Argentina, Colombia, South Africa, Saudi Arabia, UAE |
| Key companies profiled | Agilent Technologies, Analytik Jena, Bio-Rad Laboratories, Bruker Corporation, Cleaver Scientific, Danaher Corporation, Eurofins Scientific, Horiba, Jeol, Merck KGaA, PerkinElmer Inc, Promega Corporation, Qiagen NV |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy